Community Contributor
Member since 2025
Views
1.7k Total number of views
Fair Values Set
34 Total number of fair values set
Comments
0 Total number of comments
Followers
0 Total number of followers

No bio added yet

No link added
CDTX logo
Cidara Therapeutics

Cidara Therapeutics: The underestimated potential of CD388

Summary CD388 is a universal long-lasting influenza drug against all seasonal and pandemic influenza viruses in a phase 2b clinical trial. CD388 is not a vaccine but would provide 6 months of protection.Read more

View narrative
1.7k
users have viewed this narrative
9users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
US$100
121.4% overvalued intrinsic discount
Fair Value
Profit Margin
19.58%
Future PE
26.11x
Price in 2035
US$14.2k